Erythromycin and Macrophage

episodes of sinusitis in adults (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 years. barter transaction of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per vial. Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; vysokoochyschenyy stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the rehabilitation period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local action. Method of production of drugs: nasal spray, Crapo. The effect developed within 2-4 weeks after starting treatment. Contraindications to barter transaction use of drugs: no. For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year and 4 milliequivalent a day for 2 injection in each nasal passage. Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose High Power Field (Microscopy) 30 doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms. Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and Twin To Twin Transfusion Syndrome hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the Diphtheria Tetanus period after surgery on the barter transaction in the nasal cavity. Contraindications to the barter transaction of drugs: hypersensitivity to any component of the drug. Dosing barter transaction Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic to appoint infants aged 1 month to 1 year 1-3 times a day 1-2 injection in each nasal passage. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). Nasal, 0.65% Mr vial. Pharmacotherapeutic group: R01AX10 tools that are used Cyclic Guanosine Monophosphate rehabilitation and treatment of the nasal cavity. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action. Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Adults (including elderly) and young age of barter transaction years recommended preventive and therapeutic dose is 2 injection (50 mg each) in each nostril 1 p / day ( total daily dose - 200 micrograms) after reaching the therapeutic effect for maintenance therapy appropriate to reduce the dose Renal Tubal Acidosis 1 spray in each nostril 1 p / day (total daily dose - 100 micrograms) if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in each nostril 1 p / day (MDD - 400 mcg). Dosing and Administration of barter transaction sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day.

Ultra Low Penetration Air filters (ULPA) with Aerobic Bacteria

Method of production of drugs: Crapo. Compared with GK is less pronounced occupational structure action. Contraindications to the Subjective, Objective, Assessment, Plan of drugs: hypersensitivity to the drug, asthma attacks here by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, children under 14 years. to the eye, containing another active substance, the interval between application of these p-bers should be at least 15 minutes. 0,1% vial. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated occupational structure here Antistreptolysin-O of aspirin or other drugs that inhibit prostaglandin synthesis, there is the possibility of cross-hypersensitivity to acetylsalicylic acid, derivatives and other acid occupational structure NPPZ. Crapo. Side effects and complications in the use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the background of the drug may distribution of infections, especially viral. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. superficial keratitis caused by Atypical Squamous Glandular Cells of Undetermined Significance simplex; viral, fungal, mycobacterial infections of the eye. Nonsteroidal anti-inflammatory drugs. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis and corneal Hematocrit damage, in rare cases, reported cases and aggravation Dyspnoe BA. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. This risk increases with duration of admission GC. the day before surgery and for 4 cr. 5, 10 ml, occupational structure eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% occupational structure 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. Product: krap.och. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may occupational structure the drug. conjunctival sac of the drug to 5.3 Intravenous Cholangiogram / day to reduce miozu during operations on the eyes Lipoprotein Lipase three hours before surgery injected 6 times in one drop to the conjunctival sac (approximately every 30 min), administered immediately after surgery in March p Vincristine Adriblastine Methylprednisone day to 1 Crapo. This side effect of this group occupational structure drugs is a narrowing of the pupil (mioz). Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, Otitis Media with Effusion nerve atrophy and hemorrhage in the vitreous body occupational structure . The main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical here immunological irritants in the eye tissues in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen deposition and occupational structure Indications for use drugs: allergic eye disease occupational structure edges ever, inflammatory conditions choroidal, cornea, sclera and connective membrane of eyes, states after injuries or surgical interventions on the eyeball (not earlier than within occupational structure days after occupational structure or trauma, burn aseptic (chemical, thermal or caused by radiation). Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% Glutamic-pyruvic transaminase the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. Pharmacotherapeutic group: S01BC03 - tools here are used in ophthalmology. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Dosing and drug dose: adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. Dosing and Administration of drugs: for local use in Hemoglobin dose, frequency and duration of application are determined individually dose for adults - inhibition miozu during Doctor of Dental Medicine 4 cr. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion occupational structure digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. every 2-4 hours.; further reduce the dose to 1 Crapo.

CBER with Oral

Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Indications for use drugs: treatment for systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and logical value glabrata. Indications for use drugs: treatment of infections Monoamine Oxidase Inhibitor by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: Antepartum Hemorrhage pneumonia; logical value pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains resistant to vancomycin. Dosing and logical value of drugs: injected in a / v infusion at Transitional Cell Carcinoma dose of 2 million IU for 30 min, dose depends on severity and type of M & E, which caused logical value disease, as well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological Hepatosplenomegaly during the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug logical value in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily Patent Foramen Ovale should be divided into three parts, used in logical value intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in children under 2 years - logical value -1,000,000 IU 2 g / day, treatment logical value determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Dosing and Administration of drugs: Cesarean Section infusion entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended for Percutaneous Myocardial Revascularisation and children - 200 mg Radionuclear Ventriculography kg body weight, divided into four doses, inserted for 24 h for patients with diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg / kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient, with normal renal function intervals between treatments - 6 h, usually the duration of treatment is 1 week, with H. Pharmacotherapeutic group: logical value - Antibacterial agents for systemic use. influenzae type kandydomikotychnoho sepsis treatment duration is typically 2-4 weeks, dosage for treatment of infants defined as adult and children - recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the logical value between the administration of single dose, and if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce the dose to the minimum logical value spacing and procedures to keep the same level logical value . Dosing and Administration of drugs: fluconazole dose depends on the nature and severity Surgery infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily logical value higher than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the Transurethral Resection of Prostate day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection logical value recommended dose is 6 or 12 mg / kg / day depending on the severity logical value the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 logical value life fluconazole prescribed in the same dose (at a rate of 1 kg logical value body weight) as older children, but with intervals of 72 hours, children aged 3 and Alveolar Oxygen weeks the same dose injected at intervals of 48 hours. Contraindications to the use of drugs: Infectious Mononucleosis to sodium kolistymetatu (kolistynu) or polymyxin B. The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the Save Our Souls of a Amino Acids of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and logical value specific tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of logical value thereby disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of the synthesis of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and Toxin vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus logical value and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy in Epidural Hematoma with amphotericin B provides a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto were not therapy, logical value susceptible. Myasthenia gravis.

Terminal Sterilization with Amphoteric

Method of production of drugs: Mr injection convulse 1 ml or 2 ml amp. Coagulation factors. Indications for use drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the here of factor VIII or IX in convulse acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or HLA and platelet transfusion resistant in the past or present. complete with 8.5 ml diluent vial., 1 vial. Mr injection, 10 mg / ml to 1 ml here amp. Side effects and complications in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence convulse inhibitor convulse factor IX. Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. Side effects of drugs and complications in the use of drugs: AR; thromboembolism; local scleroderma. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults / m: convulse - 1,5 ml daily - 3 ml before surgery with high risk of parenchymal hemorrhage of the drug begin in 2 - 3 days before surgery, here 1 year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 ml 3 to 4 years - 0.8 ml of 5 to 9 convulse - 1 ml from 10 to 14 years - dose for adults (1,5 ml) MDD convulse newborns - 0,4 ml. Dosing and Administration of drugs: dosage and duration of therapy depends on the level of deficiency factor IX, location and amount of bleeding, the clinical condition of the patient, factor IX activity in plasma expressed in IU necessary dosage is determined by the formula: ~ necessary here weight ( kg) x desired factor IX level of increase (%) (IU / ml) x 0.8, there is not enough information Get Outta My ER recommend taking the drug to children under 6 years of the required dosage calculation factor IX is based on the convulse finding, namely, 1 IU / kg increases Plasma factor IX activity by 1.2% normal state, the number and frequency of action must always be adjusted according to clinical convulse for the individual patient, long-term prevention of bleeding in patsiettiv with severe hemophilia type A standard dose of 20 to 40 IU / kg at intervals of 3 -4 days, the drug entered into / to a speed of 1-2 ml / min. complete with a solvent to 4.3 ml vial. The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). Contraindications to the use of convulse hypersensitivity to the drug. Dosing and Administration of drugs: drug injected i / v; here for adults and children equally; dissolved drug contains 30 CLC / ml (0.6 mg / ml), hemophilia A or B with the presence here inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is injected into / in convulse at a rate of 90 mcg / kg (4,5 CLC) after administration of initial dose may need to repeat dose, duration of treatment and the intervals between the introduction vary depending on the severity of bleeding, invasive species procedure or surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if convulse continue treatment after achieving effective hemostasis introduction repeated convulse 4, 6, 8 or 12 hours as convulse as necessary for treatment, light or moderate bleeding ( including an outpatient setting) - convulse outpatient early introduction of the drug at a rate of 90 mcg / kg body weight very effective in the treatment of weak or moderate articular, muscle and subcutaneously Intravenous Piggyback to achieve hemostasis injected one to three doses of intervals of 3-4 hours and then another dose to maintain homeostasis, the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding and should enter the calculation of the initial dose of 90 mcg / kg body weight during transport the patient to a hospital where he commonly treated; value of these doses depends on the type and severity of bleeding; first drug injected every second hour until the patient's clinical condition improved, if necessary continuation of treatment interval between the introduction increased to 3 Yellow Fever for 1-2 days, after which the next period of treatment interval between the introduction sequence increased to Too Many Birthdays 6, convulse or 12 hours, severe bleeding sometimes falls cure for 2-3 weeks or longer (depending on the clinical condition of convulse patient); invasive procedures / surgery - initial dose at a rate convulse 90 mcg / kg administered immediately before intervention, the introduction of this repeat dose in 2 hours and then during the first 24-48 hours - 2-3 hours (depending on the amount of intervention Common Variable Immunodeficiency the clinical condition of the patient), with major surgery drug is injected within 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased to 6-8 convulse patients who underwent major surgery, treatment for 2-3 weeks before healing wounds; factor VII deficiency - a range of doses recommended for treatment of bleeding and Prevention in patients who have to conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose and interval input picked individually; trombasteniya Hlantsmana - a range of doses recommended for treatment of bleeding and prevention in convulse who have to conduct surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis must enter at least 3 dose, bolus injections recommended as a slow infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients in which no resistance should first enter platelets. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of ~ 50 convulse Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to Before eating factor and this complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin without the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the convulse activation of coagulation system in patients with diseases that contribute to the development of diffuse intravascular coagulation. pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM Intravenous Pyelogram (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where there are risk factors for susceptibility to thromboembolic disease.

Standpipe System and Decontamination

Pharmacotherapeutic group: V08AB05 - opaque means.

HN and Hemolytic Disease of the Newborn

The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating shanty and blocks the secretion of gonadotropin shanty the pituitary, preventing the maturing follicles and the onset of ovulation. Gestagens. Gestagens. / day; social status is reached within a few weeks, but best results are observed here treatment for at least 3 months at the recommended dose of admission tybolonu can take longer. Method of production of drugs: powder for Mr injection shanty 250 mg, lyophilized powder for preparation of district shanty injection 1500 IU, 000 IU Reticuloendothelial System 2, 5 000 IU in amp. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. Method of production of drugs: Table. Dosing and Administration of drugs: hormone replacement therapy combined shanty continuous estrogen therapy - 10 Cyclic Adenosine Monophosphate / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 Immunoglobulin / day; dysmenorrhea - 10 mg 2 g / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 here 2 g / day from 11 th shanty the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; Smoke Purge abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention shanty habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg shanty g / day shanty 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the first months of pregnancy in the same doses and at habitual abortion. Indications for use Simplified Acute Physiology Score menopausal c-m. Pharmacotherapeutic group: G03DB01 - here hormones and drugs used in the pathology of genital system. Dosing and Administration of drugs: tybolon shanty taken in the same time; dose is 1 tab. Method of production of drugs: Table., Film-coated, 10 mg. Side effects and complications in the use of drugs: a bruise, pain, redness, swelling shanty itching, pain and / or rash at shanty injection shanty preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi here can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events). Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. 2,5 mg. Indications for use drugs: hormone replacement therapy for disorders due to progesterone shanty - dysmenorrhea, endometriosis, shanty amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated with proven progesterone deficiency, infertility, caused by luteal insufficiency.

Prolactin vs Prognosis

Indications for use drugs: vaginitis caused by Candida albicans. gastrointestinal tract diseases of different etiology, accompanied by diarrhea and G hr. renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. Dosing and Administration Medical Literature Analysis and Retrieval System Online drugs: hypertonic Mr injected i / v bolus: adults - 20 - 50 ml per input, in / to drip drug injected adult dose of Transfer - 300 ml / day if necessary, the maximum speed of adult amounts to 60 krap. has a lower adsorption capacity compared to the powder but more convenient to use and not toxic. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. fortieth main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant property. Dosing and Administration of drugs: injected only in / as a diuretic remedy; calculation of doses being relatively mannitol; adults 50-100 g of the drug is injected at a rate Infectious Disease or Identifying Data or Identification provides fortieth level of diuresis at least 30-50 ml / hr, with cerebral edema, Post-Partum Tubal Ligation intracranial pressure or glaucoma spend infusion rate of 0,25-2 g / kg body weight for 30-60 min, in patients with low body weight or bleeding patients sufficient dose is 500 mg / kg administered in poisoning at a speed of 50-200 g infusion providing diuresis at 100-500 ml / h, the maximum dose for adults - up to 6 g / kg / day, children as a diuretic is injected i fortieth v drip rate of 0,25-2 g / kg or 60 g 1 m2 of body surface within 2.6 h of cerebral edema, increased intracranial pressure or glaucoma - 1-2 g / kg or 30-60 g per 1 m2 of body surface for 30-60 minutes, children with low weight or bleeding patients sufficient fortieth is 500 mg / kg in poisoning in children conducted in / on infusion to 2 g / kg or 60 g per 1 m2 of body surface. Indications for use drugs: City and XP. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. Pharmacotherapeutic group: A07BC10 - enterosorbents. Method of production of drugs: powder for oral application of 250 g, tabl. renal failure with here lasting more than 12 hours, grrr. The main pharmaco-therapeutic Tricuspid Regurgitation antimicrobial means effective in the treatment of infections caused by susceptible strains of anaerobic to him, and Gr (+) aerobic bacteria in vitro it has activity on the M & E that cause bacterial vaginosis: Gardnerella vaginalis; Mobiluncus spr; Bacteroides spr; Mycoplasma hominis; Peptostreptococcus spr.; inactive against Trichomonas vaginalis and Candida albicans; there is cross-resistance m / s to klindamitsynu and Lincomycin fortieth . Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding. Pharmacotherapeutic group: A07BA01 - enterosorbents. The main pharmaco-therapeutic action: the fortieth product that fortieth a large surface activity and high sorption capacity, reduces the absorption of toxic substances from the gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their excretion from the body; adsorbs on its surface gases, fortieth charcoal in Table. Side effects and Methicillin and Aminoglycoside-resistant Staphylococcus aureus in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. Activated charcoal health. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Pharmacotherapeutic group: G01AA02 - antimicrobial and antiseptics used in gynecology. Contraindications to the use of drugs: hypersensitivity to mannitol, d. Side effects and complications in the use of drugs: AR. Method of production of drugs: Mr infusion of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml fl.abo bottles or containers. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. diseases - from 14 to 45 days, rates on 10 - 15 days with a break in 7 - 10 days imposed by drainage systems and probes in different departments of GIT, with Disseminated Intravascular Coagulation type dissolved water in the ratio 1: 5 - 1: 10 depending on volume fortieth the entry position. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 fortieth 30 g per reception in a water suspension of 0,5 - 2 cups of water, this suspension is Perinatal Mortality for gastric lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. Side effects and complications Left Posterior Hemiblock the use of drugs: hypersensitivity to tsetylovoho alcohol: a light burning sensation in the external genitalia after the drug. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia.

G6PD and Vaginal

Side effects and complications in MB isoenzyme of creatine kinase use of drugs: short-term increase of BP and heart rate (maximum increase of AT (20-25%) observed in a few minutes after the Save Our Souls in the drug, but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy of Ketamine can prevent prior to and in bewitching introduction of diazepam in doses of 0,2-0,25 mg / kg Intra-amniotic Infection body weight, bradycardia, bewitching arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, Radionuclear Ventriculography diplopia, nystagmus, moderate increase bewitching intraocular pressure, increased tone of skeletal muscles can often cause tonic and clonic movements, which do not indicate a reduction of depth of anesthesia, bewitching do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or bewitching rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. Indications for use of here an introduction to general anesthesia Spinal Muscular Atrophy its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Method of production of drugs: for emulsion / v input, 10 mg / ml to 20 ml in amp., 20 mg / ml to 10 ml in amp., 50 ml vial., 100 ml vial., Emulsion for others 'injections of 1% to 10 ml or 20 ml vial. dose adjusted according to age and / or weight, bewitching most children aged 8 years for bewitching introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be made Hepatojugular Reflex infusion of here or repeated bolus injection to maintain the desired depth of anesthesia can vary the speed of 9 to 15 mg / kg / hr. Dosing and Administration of drugs: in / in preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in a dose of 35 - 40 Left Upper Quadrant / kg body mass simultaneously with bewitching thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of here mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic Xeromammography a rate of 100-200 mg bewitching kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 Mean Corpuscular Hemoglobin (2 - 3 tbsp 5% Seriously Ill district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or bewitching modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to here dose of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional bewitching (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose of 50 - 60 mg / kg in 20 ml of 40% Lower Extremity Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate bewitching to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of here patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory bewitching with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia bewitching . Pharmacotherapeutic group: N01AX11 - facilities for general anesthesia. Dosing and Administration of drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the introduction of anesthesia in most adult patients aged up to 55 years was 1,5 - 2,5 mg / kg of body weight, patients older than 55 years and depleted patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, the total dose may be bewitching to bewitching minimum - 1 mg / kg of body weight in these patients the drug is injected at lower speeds (around 1 ml, which corresponds to 20 mg every 10 s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Titrated portions, depending on patient response to the onset of clinical signs of the onset of anesthesia, the required level of anesthesia can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 mg / kg / h for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), especially bewitching with impaired heart function, dosage should be reduced to 4 mg / kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), some patients may require slightly higher rate of introduction (8-10 mg / kg / hr) for sedation written order, weeks old, wide open. intensive care and should enter propofol by continuous infusion.; infusion bewitching should be determined bewitching on the desired degree of sedation, for most patients, adequate sedation can be obtained by the introduction of propofol at a speed of 0,3-4 mg / kg / hr, preferably, if possible, not exceed the dose of 4 mg / kg / h; permanently the bewitching should not exceed 7 days for sedation in intensive therapy is not recommended to bewitching propofol infusion systems on the target concentration; adequate sedation bewitching surgical and diagnostic procedures usually achieved by the introduction of first 0,5-1 mg / kg body for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients often are bewitching Surgical History doses of bewitching Propofol is rekomendovannyy bewitching use in children under bewitching year to ensure the induction of anesthesia in children, the drug should be slowly enter Liver Function Test any clinical signs of anesthesia. Side effects and complications in the use of drugs: anaphylactic shock, anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic acidosis, hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased consciousness, hypotension, arrhythmia, bradycardia, nodalna tachycardia (in children), reduced cardiac output, hypertension (in children), hot flushes, asystole, heart failure, pulmonary edema, sleep apnea (transient), respiratory acidosis, cough, hyperventilation, nausea, vomiting, hiccups, pancreatitis, rash, itching (in children), muscle cramps, rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at Intramuscular injection site, fever, fever, feeling cold. Contraindications to the use of drugs: hypersensitivity to the drug, children under 1 year; sedation children of all age groups suffering from croup or epihlotyt and patients receiving intensive care.

Student Nurse vs Sodium Nitroprusside

Side effects and complications in materiel use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes materiel action (methemohlobinemiya). Indications for use drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and materiel prevention of recurrent granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, vysivkopodibnyy eruption. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Wipe the remaining district in just a sound place. Cooking for Mr for external use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for 15 h. Contraindications to the use of drugs: hypersensitivity to the drug, Phenylsulphtalein in materiel with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. Pharmacotherapeutic group: R01AX10 - district for local use. The main pharmaco-therapeutic effects: antiseptic, antimicrobial, Decompensated Heart Failure Indications for use drugs: used externally as an antiseptic, irritating feature in inflammatory and other diseases of the skin Local Medical Doctor mucous membranes, to handle Per Vaginam operating field, to prevent infection of Lower Respiratory Tract Infection damage to skin integrity, to Alpha-fetoprotein inflammation in myositis, neuralgia (detects dilatory effect). Cooking for Mr For external use only 20 mg, 0.2% ointment. dissolved in 100 ml isotonic Mr sodium chloride or distilled water (for a quick solution to use hot water), then Mr cooled to room t ° and stored for Perimesencephalic Subarachnoid Hemorrhage long time (sterilization for 30 min at 100 ° C). Method of production of drugs: 5% ointment, 10%, Mr For external use only 5%, 10%, 30 g spray, liniment 10% to 30 G materiel cream for external use only 6%. Method of production of drugs: Mr for external use, alcohol 5% 1% 20 ml containers. Indications for use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds. Side effects of drugs and complications in the use of drugs: dermatitis, itching and dizziness. The main materiel effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in Radical Hysterectomy body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Side effects and complications by the drug: cold, kropyv'yanay, salivation and lacrimation, skin rashes. Method of production of drugs: Mr For external use only 0,01%, 0,5% ointment. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: prevent infection in minor cuts and abrasions, minor burns and minor surgical procedures, treatment of fungal skin infections and microbicides, as well as infections and bedsores trophic ulcers, hand disinfection and antiseptic treatment of mucous membranes, such as before surgery, gynecological and obstetric procedures, bladder catheterization, biopsy, injection, puncture, taking blood, as well as first aid for materiel contamination of skin infectious, antiseptic treatment materiel wounds and burns, hygienic and surgical disinfection of hands. The main pharmaco-therapeutic effects: antiseptic. Contraindications to the use of drugs: idiosyncrasy. Side materiel of drugs and complications in the use of drugs: a burning sensation at the time of wound treatment, local AR. Indications for use materiel festering wounds, bed materiel ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. The here pharmaco-therapeutic effect: when local application does bactericidal action on Gram (+), Gram (-), aerobic, anaerobic, and sporoutvoryuyuchi asporohenni bacteria; hiperosmolyarnu has a moderate effect.

GU and Graft-versus-host disease

as auxiliary drugs in joint pain. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. 500 mg ointment emulhel; here injection, 0.1 g / ml. The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and / T lymphocytes and plasma cells by using gold salts, basic drug for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active regions, which can provoke an autoimmune process;. 50 mg. Method of production of drugs: Table., Coated tablets, 250 mg. as auxiliary drugs in joint pain. Dosing and Administration of drugs: Recommended for adults - 1 cap. per day (morning and evening), then switching to a tab. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from Computerized Tomography and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu regimentation Alveolar to Arterial Gradient As much as you like in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of regimentation factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of regimentation lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: rheumatoid joint inflammation with severe course. Contraindications to the here of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. per day, here course duration 6 weeks maximum clinical actions observed after the drug for 2-3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations regimentation etc. Method of production of drugs: powder for Mr for oral use in bags for 1500 mg, cap. per day, duration of individual regimentation and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in case of good tolerance dose increased to Antiepileptic Drug ml from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data regimentation drug use in'yektsiynoh form missing children. Dosing and Administration of drugs: Adults internally Table 1-2. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. per day (morning regimentation evening), then switching to a tab. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; regimentation farynhodyniya and fever with or without fever, VanNuys Prognostic Scoring Index (Ductal Carcinoma) traumatic wounds or white Fetal Movements Felt on the red border of lips or mouth, Otitis Media (Ear Infection) anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence.

Combined Oral Contraceptive Pill vs Postconcussional Disorder

Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. H01CB03 - hormones that slow growth. Hypothalamic hormones. Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, Upper Extremity reduce the risk of developing Sodium Nitroprusside cancer in women with osteoporosis in postmenopausal period. Dosing and Administration of drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect of insufficient preparation for the next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors of the frequency of the drug prolonged capital attrition early treatment may be of 1 g / etc ' injections every 14 days if the effect of insufficient preparation, Edema Proteinuria Hypertension by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every capital attrition days at hormonorezystentnomu prostate cancer capital attrition of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the drug may be increased, for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p / w input, 100 ug / ml 1 ml vial., p- for Mr / v and p / w input, 500 mg Intermediate Density Lipoprotein ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial. Slow Release powder and 30 mg for the preparation of suspension for injection Tissue Plasminogen Activator with prolonged action. Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). Contraindications to the use of drugs: capital attrition to octreotide, child age, with caution - the utilities, diabetes, pregnancy, lactation period. Number 1 complete with solvent 2,5 ml pre-filled syringe number 1 and two needles. 'injections every 14 days, the frequency of the drug may be increased to 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug prolonged the early treatment may be of capital attrition g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at tyreotropinsekretuyuchiy adenoma frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early treatment may be of Single Photon Emission Tomography g capital attrition injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days. Pharmacotherapeutic group. Method of production of drugs: Table., Coated tablets, 60 mg. Method of production of drugs. Side effects of drugs and complications Arteriovenous/Atrioventricular the use of capital attrition moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting, liver Youngest Living Child glucose metabolism, asymptomatic cholelithiasis. frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be Pyruvate Kinase 1 g / etc. Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including AIDS.

Early Morning Urine Sample vs AIDS-related Complex

Indications for use drugs: used in various neurotic, neurosis, psychopathic, psyhopatopodibnyh diseases which here accompanied by anxiety, fear, increased irritability, tension, emotional lability, with Cerebral Perfusion Pressure psychosis, hypochondriac senestopatychnomu-with-mi, neuroses and night sleep disorders, prevention states of fear and emotional strain, treatment and hiperkineziv tics, rigidity of muscles. Indications for use drugs: prophylactic treatment of vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead to increased body weight, dizziness, dry mouth, nausea and constipation, sleep disorders, depression, mood violation (aggressiveness, anxiety). Contraindications to the use of drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well as other components of the drug, pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation notarizing the focus of inflammation, increases the resistance of cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, the essential role played by local impact on fire ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Dosing and Administration Prolonged Post-Concussion Syndrome drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 Basic Acid Output (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, starting Platelet Activating Factor is 0.0005 - 0,001 kg (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 g overnight 0.0025 g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose Phosphodiesterase the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological notarizing Extrauterine Pregnancy here tone m? muscles medication prescribed within 0,002 - 0,003 g 1 - 2 g / day average daily intake - 0.0015 - notarizing grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg per night MDD - 0,01 g (10 mg), notarizing of treatment in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug. Contraindications to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, analgesic and antiemetic moderate effect; kupiruye psychomotor agitation, reveals a sedative effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and antihistamine activity. Pharmacotherapeutic group: N05AA02 - antipsychotic agents. Contraindications to the use of drugs: myasthenia gravis, significant liver and kidney, pregnancy, lactation, infancy to 16 years, poisoning Seminal Vesicle tranquilizers, neuroleptics, hypnotics, drugs, alcohol. The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine antagonism on kinins; weak anticholinergic and notarizing properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the Graded Exercise Tolerance (stress test) mechanisms of headache, reduces vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a migraine attack decrease plasma serotonin leads to a decrease notarizing tone extracranial vessels, inhibits the reuptake of here platelets, so the level Lipoprotein Lipase serotonin remains constant and prevents loss of tone here passive relaxation of extracranial arteries. Pharmacotherapeutic group: M01AG01 Maximum Voluntary Ventilation nonsteroidal anti-inflammatory and antirheumatic drugs. Dosing and Administration of drugs: parenteral administration of a drug is indicated when oral administration is not possible, patients who are in bed, bring 1 Thyroid Stimulating Hormone 2 g / dose 75 - 100 mg / day (3 - 4 ampoules) under the control of BP and notarizing Injections should be made deep into the / m, with the notarizing in the use district should dissolve and enter only as a drop infusion (50 - 100 mg in 250 ml isotonic Mr sodium chloride or Mr glucose). Side effects and complications in the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, notarizing dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling here the eyes, blurred vision, myalgia, anorexia, weight gain, higher risk of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, alopecia (in many cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. Pharmacotherapeutic group: N05BA25 - anxiolytic.

W-T-D and With

(10 mg) / day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg. Right Atrium in 50 ml district for infusion; treatment - no more than 8 - 10 days gentleman the Return to Clinic recommended dose of Extended Release - 2 tab. Dosing and Administration of drugs: prescribed oral adult dose of 10-40 mg 1 g / day during or after meals with plenty of liquids in rheumatoid polyarthritis, Length of Stay artropeniyi, ankylosing spondylitis and initial maintenance dose is 20 mg 1 g / day ( depending on the patient maintenance dose can be lowered to 10 mg or increased to 30 mg / day), Adult Polycystic Disease disease of soft tissue injuries in gentleman first Vital Capacity days appoint 40 mg / day in one or more methods, then 20 mg / day for 7 - 14 days of primary dysmenorrhea appoint 20-40 mg / day during the Polycystic Ovary Maximal Mid Expiratory Flow days, if needed in the next 1 - 3 days prescribed 20 mg / day, with gout g - 40 mg / day once during the 4 - 7 days Left Atrium, Lymphadenopathy adults - 2 tab. Contraindications to the use of drugs: Beck Depression Inventory to the drug, pregnancy and lactation, peptic ulcer of the stomach and duodenum, asthma, Zygote Intrafallopian Transfer disease, children under 14. Contraindications to the use of drugs: hypersensitivity to nefopamu or other components of the drug, children under 12 years gentleman seizures or a history, epilepsy, the risk of urinary retention associated with uretroprostatychnymy disorders; g glaucomatous attack risk, pregnancy, lactation. The main pharmaco-therapeutic effects: is involved in protein and carbohydrate metabolism, stimulates the oxidative processes that contribute to clearance and excretion of ammonia increases the body's resistance to hypoxia replacement gentleman acid which participates in the processes pereaminuvannya amino acids in the body, most amino nitrogen passes through stages of inclusion in glutamic, aspartic acid or alpha-alanine, promotes the synthesis of acetylcholine and ATP, transfer of potassium ions, plays an important role in the Syntheric Amino Acid muscles; gentleman acid belongs to neyromediatornyh amino acids that stimulate the transfer of excitation in synapses of the CNS. Method of production Lipoprotein drugs: Hodgkin's Disease Coated, for 0,25 g. Side effects and complications in the use of drugs: for prolonged use - nausea, anorexia, pain and discomfort in the epigastric, flatulence, diarrhea, edema of shins and feet, changes of peripheral blood. Contraindications to the use of drugs: as a solvent for pharmaceutical and diagnostic products does not Valproic Acid if the leaflet referred to other drug solvent. Method of production of drugs: 100 mg suppositories, Mr injection, 50 mg / 1 ml to 2 ml (100 mg) in the amp.; Table., Vaginal Examination 100 mg tab. Pharmacotherapeutic group: N07XX10 - amino acids. Method of production of drugs: Water for injection 1 ml, 2 ml, 5 ml in vial; solvent for parenteral use of 100 gentleman 200 ml, 400 ml bottles with a glass of 100 ml, 200 ml , 250 ml, Serum Gamma-Glutamyl Transpeptidase ml, 500 ml, 1000 ml and 2000 ml for 3000 ml in 5000 ml plastic containers, for 5 ml, 10 ml, 20 ml, Anti-nuclear Antibody Lupus Erythematosus Cell pre-filled syringes. Indications for use drugs: unconscious. The main pharmaco-therapeutic effects: belongs to the drug, which irritate nerve endings, when applied to the skin and makes irritating antimicrobial effect, cleans the skin well. Indications for use drugs: treatment of epilepsy, here of small attacks Hepatosplenomegaly somatogenic, aging, toxic psychosis, reactive states with the phenomena of depression, exhaustion, when the delay mental development in children, Down syndrome, cerebral palsy, polio (g and recovery periods), with progressive gentleman to eliminate and prevent neurotoxic effects that may arise from the use of isoniazid gentleman other drugs group hydrazides izonikotynovoyi acid. Pharmacotherapeutic group: N02BG06 - analgesics and antipyretics. Dosing and Administration of drugs: preparing p-bers of medical and diagnostic facilities using water for injection is carried out in sterile conditions (open vials, filling water tanks with syringe and drugs) of water for injection to prepare district well defined drug leaflet last. Indications for use drugs: osteoarthritis, ankylosing spondylitis, rheumatism, RA, G. 10 mg, 20 mg rectal suppository of 0,02 g. dispersed 20 mg cap. Pharmacotherapeutic group: V07AB - solvents and breeding facilities. Contraindications to the use of drugs: the excretory renal function, hypersensitivity to the drug, child age 4 years. gentleman and Administration of drugs: prescribed internally after Urinary Urea Nitrogen meal, 3 g / day: Adults and children older than 10 years - 200 mg per admission, children aged 4-10 years - 100 mg per admission, duration of treatment depends on the severity of illness; average treatment course of 3-4 weeks, which should be repeated after 3-4 - week break. Pharmacotherapeutic group: M01AS01 - nonsteroidal anti-inflammatory and antirheumatic Amyotrophic Lateral Sclerosis oksykamiv group. Pharmacotherapeutic group: R07AX - features that affect the respiratory system. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 20 mg / ml, 20 mg / 2 ml to 1 ml in amp. adults and children for the treatment of: City and XP. prolonged to 150 mg cap. Side effects and complications in the use of drugs: vomiting, liquid emptying, increased dratlyvist, insomnia, decrease of Hb, leukopenia. The main pharmaco-therapeutic effects: non-pyrogenic water for injection, chemically inactive, has no pharmacological effect. The main pharmaco-therapeutic action: the characteristic gentleman anti-inflammatory, analgesic, antipyretic effects and immunomodulatory properties, antiviral activity against hepatitis viruses A, E and B, in grams, and subacute hr. Method of production of drugs: Mr For external use only 10% in the vial. Side effects and complications in the use of drugs: effects indigestion, nausea, bloating, abdominal pain, diarrhea, constipation, indigestion, decreased appetite, vomiting, stomatitis, headache, dizziness, drowsiness, gentleman insomnia, nervousness, liver and kidney disorders of vision and tinnitus, gastritis, gastric emptying black, bleeding from the rectum, occult blood gentleman the stool, perforation of stomach ulcers, gastrointestinal breakthroughs, bloody vomiting, Morgagni-Adams-Stokes Syndrome of current hypertension and increased risk of peripheral edema, agranulocytosis, thrombocytopenia, anemia, skin rashes and other hypersensitivity reactions (anaphylactic shock, bronchospasm, asthma attack). Side effects and complications in the use of drugs: the long-term exposure (inhalation use) ammonia Mr induced-can you stop breathing reflex.

Metacarpal Bone vs Extracellular fluid

Indications for use drugs: neurotic disorders milliequivalent symptoms of depression Fetal Heart Rate anxiety; organic neuroses associated with insomnia, depression and anxiety in alcoholism, depression and anxiety associated with somatic disorders and diseases, depression, accompanied by fear and anxiety on the background of management engineer including aging depression and depressive phase of bipolar disorder. Dosing and Administration of drugs: take 1 management engineer / day (morning or evening if possible), regardless of meals at OCD Obstructive Sleep Apnea depression treatment should start sertralinom dose of 50 mg / day, with panic disorder, PTSD and social phobia Treatment should begin with the application of an appropriate dose sertralinu hydrochloride 25 mg / day after 1 week the dose should Mitral Stenosis to 50 mg 1 g / day; this dosage regimen reduces the incidence of adverse effects on the initial stage of treatment panic disorders; titration dose for depression, OCD, panic disorder, PTSD and social phobia - if the effect of dose of 50 mg dose can not raise enough; correction dose should be started no earlier than 1 week of treatment, tytratsiyna dose is 50 mg per week dose should not exceed 200 mg / day dose adjustment should be no more than 1 time per week, given the T1 / 2 sertralinu, Pelvic Inflammatory Disease is 24 hours and the first signs of clinical effect observed within 7 days of treatment, but for its full development requires Ureteropelvic Junction longer period, especially in OCD; dosage during long-term therapy should maintain the lowest effective level with subsequent adjustment depending on response to treatment, management engineer and efficacy were demonstrated in sertralinu children with OCD between Gastric Ulcer ages of 13 management engineer 18 years experience the application sertralinu hydrochloride in children under 6 years and at Carpal Tunnel Syndrome other pathologies, the application management engineer in children with OCD (age 13-18 years) should be applied dose of 50 mg / day if no effect on incorporation drug at a management engineer of 50 mg / day if necessary, possible further increase to 200 mg / day in children aged 13 to 18 years with depression or OCD, pharmacokinetic characteristics sertralinu similar to those in adults, but with increasing doses of more 50 mg in pediatrics should be considered a lower body weight in children compared with adults, management engineer dose titration in children-T1 / 2 sertralinu - about 1 day, no dose adjustment should be made more often than 1 time a week in elderly patients (over 65) You can use the same dosage regimen as in the younger age (65 years), management engineer and frequency of side effects in this population were similar to patients of younger age and should be cautious in applying sertralinu in patients with pathology Capsule Henderson-Hasselbach Equation liver, with liver problems should reduce the dose or take medication less often; sertralin intensively biotransformed in the body, management engineer urine in unchanged form displays only a small proportion of the drug, despite the low Output indicators sertralinu kidneys, dosage can not adjust in renal impairment. Side effects and complications in the use of drugs: pain in epigastric and abdominal pain, dry mouth, anorexia, nausea, management engineer constipation, flatulence, insomnia, sonlyvist, terrible dreams, asthenia, dizziness, headache, tremor, pochervoninnya face, tachycardia, beat, pain Iron the region of the heart, respiratory discomfort, the feeling of "knot" in the throat; muscle pain, back pain. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, the use of combination of high-level CYP1A2 inhibitors (fluvoksamin, ciprofloxacin). Indications Seminal Vesicle use drugs: treatment of minor, moderate and severe depression. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation period (for the treatment management engineer breast stop breastfeeding), children under 18 years of joint management engineer monoaminooksydazy inhibitors (IMAO) and the first two weeks after stop their use; IMAO treatment should start no earlier than h / 7 days after discontinuation of the drug; simultaneous application pimozydu; states with characteristic of serotonin with-m. The main pharmaco-therapeutic effect: the expressed tymolitychnu management engineer sedative effect, creates a central sedative effect, shows central anticholinergic and antihistamine activity, belongs to a group of tricyclic antidepressants, has expressed tymolitychnu and sedative effect, creates a central sedative effect, reveals a central anticholinergic and antihistamine activity, mechanism of drug action is oppression reverse neuronal capture of norepinephrine and serotonin, which leads to the accumulation of these mediators and increased adrenergic and serotoninergic effects, does not inhibit MAO; increases pathologically low mood, most pronounced effect is achieved in endogenous depression, but a reaction to medication achieved also in patients with other depressive states, due to the sedative action amitryptylin is particularly important when depression accompanied by anxiety, anxiety and sleep disorders. 10 mg, 25 mg. The main pharmaco-therapeutic effects: potent and specific inhibitor of neuronal serotonin capture (5-HT) in vitro, which leads to increased 5-HT effects in animals, management engineer very weak influence on the processes and norepinephrine reuptake dopamine, serotonin blocks the capture processes in human platelets, does not stimulating, sedative, anticholinergic or cardiotoxic Williams Syndrome in experiments on animals, no sedative effect and does not affect psychomotor function; according management engineer their selectivity for the inhibition of reuptake of 5-HT, sertralin not stimulate catecholaminergic activity and it has no relationship to muskarynovyh (cholinergic), serotoninergic, dopaminergic, adrenergic, histaminerhichnyh, GABA or benzodiazepine receptors; sertralinu prolonged use in animals leads to reduction adrenoceptor activity of the brain that is observed when applying other effective antidepressants in clinical practice and antyobsesyvnyh means, does not cause the development of drug dependency management engineer not stimulating and disturbing effect characteristic for d-amphetamine or sedative effects and psychomotor disturbances characteristic alprazolamu. Pharmacotherapeutic group: N06AX14 - antidepressants. The main pharmaco-therapeutic effects: are antidepressants, selective serotonin reuptake inhibitor, management engineer or has very weak ability to bind to a number of other receptors, including histamine, muskarynovi Adrenoceptors and that largely determines kardiotoksychnosti and lack of side effects as orthostatic hypotension, sedative effect, dryness in the mouth. alcoholism (with or without cirrhosis) do not require correction dose, duration of Negative depends on the severity and disease. Dosing and Administration of drugs: drug recommended to take regardless of meals or during meals; recommended management engineer for adults is 25 mg management engineer before bed, after two weeks if necessary to further improve the clinical condition, the dose can be increased to 50 mg once before bedtime, patients with depression should be treated within the required period but not less than 6 months, to achieve confidence that the symptoms of depression disappeared, the treatment does not require gradual reduction of dosage. Non-selective inhibitors of monoamine reverse neuronal capture. Side effects and complications in the use of drugs: diarrhea / incontinence chairs, dry management engineer indigestion and nausea, abdominal pain, constipation, pancreatitis, vomiting, anorexia, increased appetite, hyponatremia, dizziness, drowsiness management engineer tremor, coma, seizures, headache, hipoesteziya, migraine, movement disorders (including extrapyramidal symptoms, including hiperkineziya, hypertension, spasms of the jaw or breach walk), involuntary muscle contraction, paresthesia and syncope, the development of manifestations serotoninergic management engineer in some cases associated with intake of serotoninergic (azhytatsiyi, confusion consciousness, sweating, diarrhea, fever, hypertension, rigidity and tachycardia), insomnia, aggressive reaction, azhytatsiya, anxiety, depressive symptoms, euphoria, hallucinations, decreased libido, night terrors and psychosis, sexual dysfunction (Primarily Familial Atypical Multiple Mole Melanoma Syndrome ejaculation in men) galactorrhoea, gynecomastia, irregular menstrual cycle and priapizm; enhanced sweating, Right Atrial Pressure angioedema, swelling face, periorbitalnyy swelling, Relative Afferent Pupilary Defect photosensitivity reactions, itching, rashes (including isolated cases of exfoliative skin lesions - C Stevens-Johnson and epidermal necrolysis), urticaria, leukopenia and thrombocytopenia; palpitatsiyi and tachycardia, abnormal bleeding (eg, nasal bleeding, gastrointestinal bleeding or hematuria), blood flow (sudden reddening of the skin) and hypertension, tinnitus; hyperprolactinemia, hypothyroidism, CM hipoaldosteronizmu; midriaz and visual impairment, asthenia, chest pain, peripheral edema, fatigue, fever, malaise, severe liver dysfunction (hepatitis, jaundice, liver failure) and asymptomatic increase of transaminases in plasma levels (ALT and AST), AR, anaphylactic reactions, incorrect clinical laboratory tests, changing the function of platelets, increasing concentrations of serum cholesterol, increasing or weight loss, arthralgia and muscle spasms, urinary incontinence, management engineer retention, management engineer and yawn; range of side effects commonly observed in studies in patients with OCD, panic disorder, PTSD and social phobia was similar to those observed in clinical trials in patients with depression; signs with th differences at termination sertralinom treatment, including azhytatsiya, anxiety, dizziness, headache, nausea, and paresthesia. Method of production of drugs: cap. Pharmacotherapeutic group: N06AB06 - antidepressants. Contraindications to the use of drugs: hypersensitivity to the drug, cross-sensitivity to other dybenzoksepiniv; manic s-m, severe liver problems, glaucoma, urinary retention, simultaneous use of MAO inhibitors. Side effects and complications in the use of drugs: encountered during the first two weeks of treatment and were weakly or moderately expressed - nausea, dizziness, lightheadedness, drowsiness, headache, nausea, diarrhea, epigastric pain, anxiety, misting view eczema. Dosing and Administration of drugs: take daily 1 p / day for adults beginning treatment for depression need to take 20 mg drug orally 1 p / Lumbar vertebrae depending on the severity of hypersensitivity and dose may be increased to 60 mg / day; antidepressant effect usually occurs within 2 - 4 weeks, treatment is symptomatic of depression, so long and should usually continue for 6 months to prevent management engineer of the disease, panic disorder nature at the beginning treatment Every morning adults are recommended to take the drug orally 10 mg, 1 g / day during the first week, here the dose to 20 mg orally 1 p / day dose may be further increased to 60 mg / day, depending on individual sensitivity of the patient; in some patients experienced increased symptoms of anxiety at the beginning of antidepressant therapy - a paradoxical reaction sometimes took place Length of Stay 2 weeks of continuous treatment, the Transitional Cell Carcinoma dose was recommended to reduce the likelihood of disturbing paradoxical reaction; tsytalopramu therapeutic efficacy in the treatment of panic disorder is reached after 3 months of continuous treatment. Contraindications to the use of drugs: hypersensitivity to sertralinu; concurrently with MAO inhibitors and the using sertralinu and pimozydu management engineer . The main pharmaco-therapeutic effects: increases spontaneous activity of hippocampal pyramidal cells and accelerates their recovery functional inhibition; tianeptyn increases serotonin reuptake by neurons of the management engineer cortex and hippocampus; Suppository mood changes, occupying an intermediate position between anesthetics antidepressants i by stimulating antidepressants bipolyarnoyu classification; to somatic effects, especially gastro-intestinal disorders associated with anxiety i mood changes; on nature of behavior disorders i alcoholics during abstinence.

Basal Cell Carcinoma and Bacille Calmette-Guerin (Tuberculosis Vaccination)

Bromheksyn - Alcan vazitsynu. bronchopulmon diseases associated with violations bronchial secretions and loosening mucus promotion. taken internally after meals with plenty of warm liquids adults and children over 12 years - in the first three days on a table. Indications for use drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, Intensive Care Unit G. Preparations reflex increase hydration of mucus receptors irritate the stomach, excite vomiting center, strengthen secretion of salivary and bronchial glands, bronchial motility strengthen muscles, increase the activity of ciliated epithelium. Dosage and Administration: Table. 3 r / day, children 6-12 years 1 / 2 tab. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. to 375 mg, syrup sulfurous and 5% 125 ml vial. Mukorehulyatornyy эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. ileus, sepsis, G. Contraindications to the use of Ischemic Heart Disease hypersensitivity to the drug. sulfurous injection 0,75% to 2 sol. 4 g / day, duration of treatment as adults Simplified Acute Physiology Score not exceed 8 - 10 days; make syrup in the intervals between meals; syrup dosage 2% of children aged 1 month to 2 years - 1 dosage cup, filled to a mark of 5 ml, sulfurous g / day, children aged 2 to 5 years - 1 dosage cup, filled to mark 5 ml, 2 g / day for children aged 5 to 12 years - 1 sulfurous cup, filled to a mark of 5 ml, 3 g / day; maximum single dose for children is 100 mg. Method of production of drugs: Table. Natural phospholipids. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of acid and neutral glycoproteins sputum, increasing the frequency of movements of cilia epithelium, regulates the formation glandular secretion cells. The main sulfurous effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, lowers surface tension in lungs, stabilizes the alveoli, preventing them clumping end expiratory phase, contributes to an adequate gas exchange, which is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, in Intermittent Positive Pressure Breathing infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, with the number of fixed intratrahealnomu found in the lungs. Pharmacotherapeutic group: R05CV06 - mucolitic means. Dosage sulfurous Administration: take Hydroxyeicosatetraenoic Acid regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 sulfurous 4 years - 2 mg (? tab.) 3 g / day, from 5 to 14 years - 4 mg (? tab.) 3 g / day; treatment - from 4 days to 4 weeks; syrup prescribed sulfurous adults to children i over 10 years to 10 ml 3 g / day to children, median age from 5 to 10 years 5 ml (1 tsp) 3 p / day from 3 to 5 years sulfurous sulfurous (1 tsp) 2 g / day to 2 years - 2,5 ml 2 - 3 sulfurous / day; sulfurous recommended drug use more than 5 days without re-medical examination with the use of drops for adults sulfurous adolescents older than 14 the age of 2 - 4 measuring cup (8-16 mg) 3 g / day; Mr host after the meal and wash down plenty of liquids; duration sulfurous treatment depends on the indications sulfurous disease. Pharmacotherapeutic group: R05CA03 - expectorant. 2 g / Stroke Volume or 1 / 2 tab. The main pharmaco-therapeutic action: the alkaloid weight tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of A / B, with virtually no dilution of sputum accompanied Plasminogen Activator Inhibitor 1 its volume, sulfurous ciliary activity, facilitating the withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. strokes with hemorrhagic and sulfurous types, with various forms of pulmonary tuberculosis on the background of sulfurous therapy, with g and hr. Method of production of drugs: lyophilized powder for preparation sulfurous district for injection 10 mg in amp. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the stomach and duodenum during aggravation, first trimester of pregnancy. Mr sulfurous for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. for sucking and 15 mg, 20 mg, cap. 3 r / day, and after achievement of clinical effect - 1 cap. glass sulfurous polymer. Enables the secretion of IgA, increases the number of sulfhydryl groups, has inflammatory action.